About Kivi Labs Limited
Data last updated:
Kivi Labs Limited is a public limited company based in Por, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 October 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ2002PLC041375. Its GSTIN is 24AABCK9388D1ZE (Gujarat).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹35.02 Lakh. It is led by directors including Pramodkumar Atmaram Agarwal (Managing Director) and Dharmisthaben Jayeshbhai Patel (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 147 – 148 GIDC Ramangamdi Por, Gujarat, India – 391243.
As per the financials filed for FY 2025, the company reported a revenue of ₹49.23 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹1.52 Cr (net margin 3.1%) and EBITDA of ₹10.17 Cr (EBITDA margin 20.7%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 6% over five years.
The company has about 110 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹31.22 Cr and satisfied charges of ₹3.38 Cr on record. Court records list 21 cases involving the company, including 3 filed by the company and 15 filed against it; 3 cases are pending. The company has 3 deals on record (3 secondary share transfers); the latest was in September 2018. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Dosch Pharmaceuticals Pvt Ltd with revenue of ₹49.93 Cr. The company has 11 MSME Form 1 returns on record between 2019 and 2023, listing 141 overdue payments to 45 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kivilabs.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address147 – 148 GIDC Ramangamdi Por, Gujarat, India – 391243
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Kivi Labs Limited
The main business activity of Kivi Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Kivi Labs Limited FY 2025 filings available
Kivi Labs Limited reported revenue of ₹49.23 Cr (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Kivi Labs Limited
Revenue rose 6% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 6%. EBITDA rose 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Kivi Labs Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹49.23 Cr | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹10.17 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.52 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Kivi Labs Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 20.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Kivi Labs are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Kivi Labs Limited
Kivi Labs has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dharmisthaben Jayeshbhai Patel | Whole-Time Director | 04 Oct 2002 | 24 Years 0 Months | Current |
| Pramodkumar Atmaram Agarwal | Managing Director | 04 Oct 2002 | 24 Years 0 Months | Current |
| Lata Pramod Kumar Agarwal | Whole-Time Director | 04 Oct 2002 | 24 Years 0 Months | Current |
| Jayesh Bhogilal Patel | Whole-Time Director | 04 Oct 2002 | 24 Years 0 Months | Current |
Peer Comparison of Kivi Labs Limited
Kivi Labs Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dosch Pharmaceuticals Pvt Ltd | ₹49.93 Cr (FY 2019) | •••• | •••• | 23.0% | •••• | Mumbai, Maharashtra, India |
| Sotac Healthcare Private Limited | ₹49.75 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Ahmedabad, Gujarat, India |
| Riocare India Private Limited | ₹49.75 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Navi Mumbai, Maharashtra, India |
| Medipol Pharmaceutical India Private Limited | ₹49.73 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Delhi, India |
| Akron Formulations India Private Limited | ₹49.28 Cr (FY 2025) | •••• | •••• | 83.0% | •••• | Hyderabad, Telangana, India |
| Kivi Labs Limited this company | ₹49.23 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Por, Gujarat, India |
| Century Super Speciality Hospitals Private Limited | ₹49.06 Cr (FY 2025) | •••• | •••• | 151.0% | •••• | Hyderabad, Telangana, India |
| Atoz Pharmaceuticals Private Limited | ₹49.04 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Ambattur Chenai, Tamil Nadu, India |
| Protech Bio Systems Private Limited | ₹48.99 Cr (FY 2025) | •••• | •••• | -17.0% | •••• | New Delhi, Delhi, India |
| Montage Laboratories Private Limited | ₹48.49 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Himatnagar, Gujarat, India |
| Sainor Pharma Private Limited | ₹48.47 Cr (FY 2016) | •••• | •••• | 0.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Kivi Labs by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Kivi Labs Limited
Kivi Labs Limited is audited by Rajesh Nagda & Co. for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Rajesh Nagda & Co. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Kivi Labs Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Kivi Labs Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Dec 2025 | Hdfc Bank Limited | ₹1.26 Cr | Open |
| 30 Sep 2025 | Hdfc Bank Limited | ₹20 Cr | Open |
| 31 Mar 2025 | Hdfc Bank Limited | ₹30.5 Lakh | Open |
| 29 Oct 2024 | Hdfc Bank Limited | ₹87 Lakh | Open |
| 31 Jul 2023 | Others | ₹87 Lakh | Open |
Total charge records: 22 View all charges
Deals & Funding of Kivi Labs Limited
Kivi Labs Limited has 3 deals on record (3 secondary share transfers); the latest was in September 2018.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2018 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Dec 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Sep 2013 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
Full deal history
All 3 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Kivi Labs Limited
Kivi Labs Limited has 21 court cases on record: 3 filed by Kivi Labs, 15 filed against it, 3 where it is another party. 3 cases are pending and 18 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 15 | 12 | 0 |
| District courts | 6 | 3 | 3 |
Cases on record (5 of 21)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Court case (CS CCC) | Filed against the company by Tripada Healthcare Private Limited | Pending |
| High Court of Delhi | Court case (CS(OS)) | Filed against the company by Sun Pharma Laboratories Limited | Disposed |
| District court, Ahmedabad, Gujarat | Court case (CS CCC) | Filed against the company by Intas Pharmaceuticals Limited | Disposed |
| District court, Thane, Maharashtra | Court case (R.C.C.) | Company is another party | Pending |
| District court, Vadodara, Gujarat | Criminal complaint | Company is another party | Pending |
Full case history
All 21 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Kivi Labs Limited
Kivi Labs Limited has 11 MSME Form 1 returns on record between 2019 and 2023, listing 141 overdue payments to 45 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 45)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Enngees Intra Chem | •••• | •••• | •••• |
| BRK Industries LLP | •••• | •••• | •••• |
| Imex Overseas | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 11 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Kivi Labs Limited
Kivi Labs Limited has a workforce of 110 employees as of Sep 22, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Kivi Labs Limited
Kivi Labs Limited has 8 board changes on record since 2002: 4 appointments and 4 cessations. The latest: Jaykishan Jayeshbhai Patel ceased to be Director on 12 Jun 2013.
32 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Kivi Labs Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Kivi Labs Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Kivi Labs Limited
Kivi Labs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AABCK9388D1ZE | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Kivi Labs Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kivi Labs Limited
Kivi Labs is an active public limited company based in Por, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 October 2002 (24+ years old) and is registered under CIN U24231GJ2002PLC041375.
Kivi Labs reported revenue of ₹49.23 Cr for FY 2025 (up 6% YoY).
Kivi Labs has 4 current directors:
- Pramodkumar Atmaram Agarwal - Managing Director
- Dharmisthaben Jayeshbhai Patel - Whole-Time Director
- Lata Pramod Kumar Agarwal - Whole-Time Director
- Jayesh Bhogilal Patel - Whole-Time Director
Kivi Labs reported a net profit of ₹1.52 Cr (net margin 3.1%) and EBITDA of ₹10.17 Cr (EBITDA margin 20.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Kivi Labs is 3% over three years and -6% over five years. In the latest year (FY 2025) revenue rose 6%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Kivi Labs is 24AABCK9388D1ZE, registered in Gujarat.
The CIN (Corporate Identification Number) of Kivi Labs is U24231GJ2002PLC041375. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kivi Labs has 21 court cases on record: 3 filed by the company and 15 filed against it. 3 are pending. Most are in the high courts.
Kivi Labs was incorporated on 04 October 2002, making it 24+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Kivi Labs has 3 deals on record (3 secondary share transfers); the latest was in September 2018.
The peers of Kivi Labs by revenue are Dosch Pharmaceuticals Pvt Ltd, Sotac Healthcare Private Limited, Riocare India Private Limited, Medipol Pharmaceutical India Private Limited, Akron Formulations India Private Limited and 5 more, all in the Pharma industry (Formulations).
Jaykishan Jayeshbhai Patel ceased to be Director on 12 Jun 2013. Megh Shyam Damodar Lal Gupta ceased to be Director on 12 Jun 2013. Rakesh Radhey Shayam Gupta ceased to be Director on 12 Jun 2013. Kivi Labs has 8 board changes on record in total.